Amy K Darke

Amy K Darke

UNVERIFIED PROFILE

Are you Amy K Darke?   Register this Author

Register author
Amy K Darke

Amy K Darke

Publications by authors named "Amy K Darke"

Are you Amy K Darke?   Register this Author

20Publications

548Reads

24Profile Views

Long-Term Effects of Finasteride on Prostate Cancer Mortality.

N Engl J Med 2019 01;380(4):393-394

CHRISTUS Santa Rosa Hospital Medical Center, San Antonio, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1809961DOI Listing
January 2019

Response to H. Nabi et al.

J Natl Cancer Inst 2018 12;110(12):1424-1425

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658869PMC
December 2018

Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE).

JAMA Neurol 2017 05;74(5):567-573

Sanders-Brown Center on Aging, University of Kentucky, Lexington2Alzheimer's Disease Center, University of Kentucky, Lexington9Department of Neurology, College of Medicine, University of Kentucky, Lexington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2016.5778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506489PMC
May 2017

A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Cancer Prev Res (Phila) 2014 Sep 3;7(9):950-7. Epub 2014 Jun 3.

Departments of Pathology, Microbiology and Immunology, Cancer Biology, and Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154984PMC
September 2014

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

J Natl Cancer Inst 2014 Mar 22;106(3):djt456. Epub 2014 Feb 22.

Affiliations of authors: Cancer Prevention Program (ARK) and SWOG Statistical Center (AKD, CMT, PJG), Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology (ARK, GEG) and Department of Environmental Health (GEG), University of Washington, Seattle, WA; University of Missouri, Research Reactor Center, Columbia, MO (JSM); Harry S. Truman Memorial Veterans Hospital, Columbia, MO (JSM); Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX (IMT); Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA (FLM); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD (LMM, HLP); Moores Cancer Center, University of California San Diego, San Diego, CA (SML); Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH (EAK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt456DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975165PMC
March 2014

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

J Natl Cancer Inst 2013 Aug 10;105(15):1132-41. Epub 2013 Jul 10.

Department of Internal Medicine, Division of Cancer Prevention and Control, The Ohio State University College of Medicine, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735464PMC
August 2013

Health-related quality-of-life findings for the prostate cancer prevention trial.

J Natl Cancer Inst 2012 Sep 12;104(18):1373-85. Epub 2012 Sep 12.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, M3-C102 1100 Fairview Ave North, PO Box 19024 Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529595PMC
September 2012

Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.

Biostatistics 2010 Jul 19;11(3):413-8. Epub 2010 Feb 19.

Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, Bethesda, MD 20892-7354, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/biostatistics/kxq004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883301PMC
July 2010

Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

J Natl Cancer Inst 2007 Sep 11;99(18):1375-83. Epub 2007 Sep 11.

Department of Pathology, University of Colorado Denver and Health Sciences Center, 4200 E Ninth Ave, Box B-216, Denver, CO 80262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djm117DOI Listing
September 2007

Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

J Natl Cancer Inst 2007 Jul 27;99(13):1025-35. Epub 2007 Jun 27.

Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center/M3-C102, 1100 Fairview Ave North, Box 19024, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djm023DOI Listing
July 2007